Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic allograft nephropathy.

Behzad Najafian1, Bertram L Kasiske

  • 1Department of Laboratory Medicine and Pathology, University of Minnesota, USA.

Current Opinion in Nephrology and Hypertension
|February 16, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitochondrial respiratory capacity in kidney podocytes is high, age-dependent, and sexually dimorphic.

Kidney international·2026
Same author

Dynamic and differential renal cortical cell-specific mitochondrial metabolism in response to fasting.

American journal of physiology. Renal physiology·2025
Same author

AJKD Atlas of Renal Pathology: Lysozyme-Associated Nephropathy.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2025
Same author

Heterogeneity in the relationships between albuminuria and glomerular structure in type 1 and type 2 diabetes.

Kidney international·2025
Same author

Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2024 Clinical Practice Guideline.

Annals of internal medicine·2025
Same author

AJKD Atlas of Renal Pathology: Crystalglobulin-Induced Nephropathy.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2025
Same journal

Sex differences in renal acid-base regulation.

Current opinion in nephrology and hypertension·2026
Same journal

Primary prevention of chronic kidney disease in type 2 diabetes mellitus with sodium-glucose cotransporter 2 inhibitors.

Current opinion in nephrology and hypertension·2026
Same journal

Financial and policy challenges of delivering kidney replacement therapies in resource-limited settings.

Current opinion in nephrology and hypertension·2026
Same journal

The role of kir4.1/Kir5.1 in mediating the effect of angiotensin-II on Na-Cl-cotransporter.

Current opinion in nephrology and hypertension·2026
Same journal

Role of the calcium-sensing receptor in regulating calcium transport in the thick ascending limb.

Current opinion in nephrology and hypertension·2026
Same journal

Social determinants of chronic kidney disease: from association to clinical and population action.

Current opinion in nephrology and hypertension·2026
See all related articles

Long-term kidney transplant success remains limited, with chronic allograft nephropathy being a major cause of graft failure. Research suggests early rejection and medication toxicity contribute to this condition, necessitating further investigation into its causes and treatments.

Area of Science:

  • Nephrology
  • Transplantation Immunology
  • Immunosuppression

Background:

  • Long-term kidney allograft survival has seen minimal improvement despite advances in preventing acute rejection and early graft loss.
  • Chronic allograft nephropathy (CAN) is the primary cause of late kidney allograft failure, but its underlying mechanisms and effective treatments are poorly understood.

Purpose of the Study:

  • To review recent findings on the pathogenesis of chronic allograft nephropathy (CAN) after kidney transplantation.
  • To identify potential contributing factors to late allograft failure and explore current therapeutic approaches.

Main Methods:

  • Review of recent scientific literature on kidney transplantation outcomes and chronic allograft nephropathy.
  • Analysis of studies investigating the roles of acute rejection, calcineurin inhibitor toxicity, and antibody-mediated injury in CAN.

Related Experiment Videos

Main Results:

  • Early acute rejection and subsequent calcineurin inhibitor toxicity are implicated in the development of CAN.
  • Antibody-mediated rejection, particularly in cases of transplant glomerulopathy, is increasingly recognized as a significant factor in CAN pathogenesis.
  • Current therapeutic strategies, such as reducing calcineurin inhibitor exposure, lack robust clinical evidence.

Conclusions:

  • Understanding the complex etiology of late kidney allograft failure due to CAN is a critical research priority.
  • Further research is needed to elucidate the mechanisms of CAN and develop effective treatment protocols to improve long-term transplant outcomes.